Exchange Agreements in the Life Sciences Tools & Services Industry
19 Contracts & Agreements
- ARQULE INC (2 contracts)
- Bio-Rad Laboratories (1)
- CHAMPIONS ONCOLOGY, INC. (3)
- ChromaDex Corp. (1)
- ECO SCIENCE SOLUTIONS, INC. (1)
- EVIO, INC. (1)
- HighCape Capital Acquisition Corp. (2)
- IQVIA Holdings Inc. (1)
- MARAVAI LIFESCIENCES HOLDINGS, INC. (2)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (1)
- PRESSURE BIOSCIENCES INC (1)
- SeqLL, Inc. (1)
- Singular Genomics Systems, Inc. (1)
- Thermo Fisher Scientific (1)
- Exchange Agreement, dated as of January 26, 2022, by and among the Company, Deerfield Private Design Fund IV, L.P. and Deerfield Partners, L.P (Singular Genomics Systems, Inc., Filed With SEC on January 26, 2022)
- Technology and Services Exchange Agreement, dated as of February 17, 2021, by and among Q-SI Operations Inc. (formerly Quantum-Si Incorporated) and the participants named therein (HighCape Capital Acquisition Corp., Filed With SEC on November 15, 2021)
- Technology and Services Exchange Agreement, dated as of February 17, 2021, by and among Quantum-Si Incorporated and the participants named therein (HighCape Capital Acquisition Corp., Filed With SEC on March 1, 2021)
- Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. and the other signatories party thereto (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on November 25, 2020)
- Form of Exchange Agreement (MARAVAI LIFESCIENCES HOLDINGS, INC., Filed With SEC on November 9, 2020)
- Form of $825,930 exchange agreement, Dated 7/1/19 (EVIO, INC., Filed With SEC on May 20, 2020)
- Exchange Agreement dated September 30, 2018 by and between SeqLL Inc. and St. Laurent Investments, LLC (SeqLL, Inc., Filed With SEC on April 23, 2019)
- THERMO FISHER SCIENTIFIC INC. 500,000,000 1.450% Senior Notes due 2027 UNDERWRITING AGREEMENT March 7, 2017 CreditSuisse Securities (Europe) Limited HSBC Bank plc BNP Paribas... (Thermo Fisher Scientific, Filed With SEC on March 8, 2017)
- ***TextOmitted and Filed Separatelywiththe Securities and Exchange Commission.ConfidentialTreatment RequestedUnder17 C.F.R. Sections 200.80(b)(4) and Rule 24b-2 of... (ChromaDex Corp., Filed With SEC on November 10, 2016)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION SECOND LEASE... (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on August 4, 2016)
- OPTION EXCHANGE AGREEMENT (CHAMPIONS ONCOLOGY, INC., Filed With SEC on July 22, 2016)
- OPTION EXCHANGE AGREEMENT (CHAMPIONS ONCOLOGY, INC., Filed With SEC on July 22, 2016)
- OPTION EXCHANGE AGREEMENT (CHAMPIONS ONCOLOGY, INC., Filed With SEC on July 22, 2016)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT... (ARQULE INC, Filed With SEC on August 5, 2015)
- SECURITIES PURCHASE AND EXCHANGE AGREEMENT (PRESSURE BIOSCIENCES INC, Filed With SEC on December 31, 2014)
- AGREEMENT AND PLAN OF SHARE EXCHANGE (IQVIA Holdings Inc., Filed With SEC on February 15, 2013)
- SHARE EXCHANGE AGREEMENT (ECO SCIENCE SOLUTIONS, INC., Filed With SEC on August 24, 2012)
- LICENSE AND CO-COMMERCIALIZATION AGREEMENT BY AND BETWEEN ARQULE, INC. and DAIICHI SANKYO CO., LTD November 8, 2011 [*] = CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND... (ARQULE INC, Filed With SEC on March 1, 2012)
- Bio-Rad Laboratories, Inc. 6.125%Senior Subordinated Notes due 2014 Exchange and Registration Rights Agreement (Bio-Rad Laboratories, Filed With SEC on April 20, 2005)